MedPath
NMPA Approval

Fluticasone Propionate and Formoterol Fumarate Aerosol for Inhalation

国药准字HJ20230107

September 12, 2023

Drug Information

氟替卡松福莫特罗吸入气雾剂

吸入气雾剂

每罐120揿,每揿含丙酸氟替卡松125μg和富马酸福莫特罗5μg,递送剂量为丙酸氟替卡松115μg和富马酸福莫特罗4.5μg

化学药品

September 12, 2023

September 11, 2028

Company Information

Applicant Company

CAMBRIDGE SCIENCE PARK, MILTON ROAD, CAMBRIDGE, CB4 0GW, UNITED KINGDOM

Manufacturing Company

recipharm hc limited

LONDON ROAD, HOLMES CHAPEL, CREWE, CW4 8BE, UNITED KINGDOM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氟替卡松福莫特罗吸入气雾剂 - NMPA 批准文号 | MedPath